XML 33 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Cash flows from operating expenses:    
Net loss $ (1,652,618) $ (1,456,624)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 2,131 1,927
Amortization of debt issuance costs 67,245   
Amortization of discount on convertible debentures 319,225   
Interest income on short-term investment (115) (105)
Change in fair value of financial instruments (290,973) (34,224)
Stock-based compensation 305,517 416,219
Bad debts expense    53,111
Cancellation of trade liabilities and unpaid interest    (31,447)
Changes in operating assets and liabilities:    
Accounts receivable (390,299) (244,908)
Costs and estimated earnings in excess of billings on uncompleted contracts (287,894) 58,347
Inventory (164,914) (9,820)
Prepaid expenses and other current assets (8,088) (1,405)
Security deposit (12,000)   
Accounts payable and accrued expenses 602,323 55,561
Accrued interest, related party 6,131 6,154
Accrued interest 51,530   
Related party accounts payable and accrued expenses 105,514 50,731
Billings in excess of costs and estimated earningson uncompleted contracts (42,790) 81,117
Deferred revenue 237,742 120,900
Net cash used in operating activities (1,152,333) (934,466)
Cash flows used in investing activities    
Purchase of equipment (8,785) (549)
Net cash used in investing activities (8,785) (549)
Cash flows from financing activities:    
Expenditures on debt issuance costs (28,000)   
Proceeds from common stock to be issued    14,000
Proceeds from issuance of common stock and warrants in private offering    642,183
Proceeds from issuance of convertible debentures and warrants 850,000   
Net cash provided by financing activities 822,000 656,183
Effect of exchange rate changes on cash (4,369) (634)
Net decrease in cash (343,487) (279,466)
Cash and cash equivalents - beginning of period 868,067 561,759
Cash and cash equivalents - end of period 524,580 282,293
Cash paid during the period for:    
Interest      
Supplemental disclosure of non-cash financing activities:    
In connection with the 2012 private offering, $80,000 was paid for a prior liability which was included in accounts payable and accrued expenses.      
Issuance of common stock for settlement of debt    67,782
Forgiveness of related party accrued compensation    $ 73,888